The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Open accessAbstract
The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of the genome and transcriptome from representative numbers of patients. We present an integrated analysis of copy number and gene expression in a discovery and validation set of 997 and 995 primary breast tumours, respectively, with long-term clinical follow-up. Inherited variants (copy number variants and single nucleotide polymorphisms) and acquired somatic copy number aberrations (CNAs) were associated with expression in ~40% of genes, with the landscape dominated by cis- and trans-acting CNAs. By delineating expression outlier genes driven in cis by CNAs, we identified putative cancer genes, including deletions in PPP2R2A, MTAP and MAP2K4. Unsupervised analysis of paired DNA–RNA profiles revealed novel subgroups with distinct clinical outcomes, which reproduced in the validation cohort. These include a high-risk, oestrogen-receptor-positive 11q13/14 cis-acting subgroup and a favourable prognosis subgroup devoid of CNAs. Trans-acting aberration hotspots were found to modulate subgroup-specific gene networks, including a TCR deletion-mediated adaptive immune response in the ‘CNA-devoid’ subgroup and a basal-specific chromosome 5 deletion-associated mitotic network. Our results provide a novel molecular stratification of the breast cancer population, derived from the impact of somatic CNAs on the transcriptome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently, numerous research efforts are focused on utilizing genetic data and artificial intelligence algorithms to develop diagnostic models to enhance the clinical efficiency and accuracy of breast cancer diagnosis [109,110,111].”
From A Comprehensive Review on Synergy of Multi-Modal Data and AI Technologies in Medical Diagnosis (2024) · cites this paper as [111]
In the citing paper
“This framework was also employed for a landmark study which used genomic and transcriptomic data from 2,000 breast tumours and discovered novel subgroups amongst them (Curtis et al., 2012).”
From Using machine learning approaches for multi-omics data analysis: A review (2021) · cites this paper as Curtis et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Self-citationSupervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S. C. Y., Voduc, D. K., Vickery, T. L., Davies, S. R., Fauron, C. M. ‐., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,818
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Ki67 expression in breast cancer
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Diagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R. J., Hastie, T. J., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,931
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,411
Self-citationGenomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A. V., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,309
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T., Shih, I., Mao, T., Nakayama, K., Roden, R. B. S., Glas, R., Slamon, D. J., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,218
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,028
Abdel-Fatah, T. M. A., Middleton, F. K., Arora, A., Agarwal, D., Chen, T., Moseley, P. M., Perry, C., Doherty, R. E., Chan, S. Y. T., Green, A. R., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.10.013 · Cited by 86
Self-citationBaccelli, I., Stenzinger, A., Vogel, V., Pfitzner, B. M., Klein, C., Wallwiener, M., Scharpff, M., Saini, M., Holland‐Letz, T., Sinn, H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2385 · Cited by 86
Damelin, M. I., Bankovich, A. J., Park, A., Aguilar, J., Anderson, W. C., Santaguida, M. A., Aujay, M. A., Fong, S., Khandke, K. M., Pulito, V. L., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0695 · Cited by 86
Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesisPreprint
Wassef, M. A., Rodilla, V., Teissandier, A., Zeitouni, B., Gruel, N., Sadacca, B., Irondelle, M., Charruel, M., Ducos, B., Michaud, A., et al. (2015) · Genes & Development · doi:10.1101/gad.269522.115 · Cited by 95
Lawrenson, K., Kar, S., McCue, K., Kuchenbaecker, K. B., Michailidou, K., Tyrer, J. P., Beesley, J., Ramus, S. J., Li, Q., Delgado, M. K., et al. (2016) · Nature Communications · doi:10.1038/ncomms12675 · Cited by 85
Self-citationThe Genomic Landscape of Mucinous Breast Cancer
Pareja, F. G., Lee, J. Y., Brown, D. N., Piscuoglio, S., Gularte‐Mérida, R., Selenica, P., Paula, A. D. C., Arunachalam, S., Kumar, R., Geyer, F. C., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy216 · Cited by 85
Personalization of Logical Models With Multi-Omics Data Allows Clinical Stratification of Patients
Béal, J., Montagud, A., Traynard, P., Barillot, E., & Calzone, L. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01965 · Cited by 85
Patterns of Genomic Instability in Breast Cancer
Kalimutho, M., Nones, K., Srihari, S., Duijf, P. H. G., Waddell, N., & Khanna, K. K. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.01.005 · Cited by 87
Fahrmann, J. F., Vykoukal, J. V., Fleury, A., Tripathi, S. C., Dennison, J. B., Murage, E. N., Wang, P., Yu, C., Capello, M., Creighton, C. J., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz182 · Cited by 85
New Advances in Molecular Breast Cancer Pathology
Rakha, E. A., & Pareja, F. G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.014 · Cited by 85
Zhang, Y., Wu, M., Lu, W.-C., Li, Y., Chang, C. J., & Yang, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.003 · Cited by 88
Rudolph, M., Anzeneder, T., Schulz, A., Beckmann, G., Byrne, A. T., Jeffers, M., Peña, C. E., Politz, O., Köchert, K., Vonk, R., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2626-1 · Cited by 85
Reimagining psychoses: An agnostic approach to diagnosis
Keshavan, M. S., Clementz, B. A., Pearlson, G. D., Sweeney, J. A., & Tamminga, C. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.022 · Cited by 88
Li, A. M., Ducker, G. S., Li, Y., Seoane, J. A., Xiao, Y., Melemenidis, S., Zhou, Y., Liu, L., Vanharanta, S., Graves, E. E., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0606 · Cited by 84
Self-citationSOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis
Ma, Y., Shepherd, J., Zhao, D., Bollu, L. R., Tahaney, W. M., Hill, J. L., Zhang, Y., Mazumdar, A., & Brown, P. H. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0311 · Cited by 85
Zeleke, T. Z., Pan, Q., Chiuzan, C. C., Onishi, M., Li, Y., Tan, H., Alvarez, M. J., Honan, E., Yang, M., Chia, P. L., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00489-5 · Cited by 84
A network-assisted co-clustering algorithm to discover cancer subtypes based on gene expression
Liu, Y., Gu, Q., Hou, J. P., Han, J., & Ma, J. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-37 · Cited by 84
Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
Maubant, S., Tesson, B. M., Maire, V., Ye, M., Rigaill, G. J., Gentien, D., Cruzalegui, F. H., Tucker, G. C., Roman‐Roman, S., & Dubois, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122333 · Cited by 85
Bergstrom, E. N., Abbasi, A., Díaz-Gay, M., Galland, L., Ladoire, S., Lippman, S. M., & Alexandrov, L. B. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02641 · Cited by 83
Batra, R. N., Lifshitz, A., Vidaković, A. T., Chin, S., Sati-Batra, A., Sammut, S., Provenzano, E., Ali, H. R., Dariush, A. A., Bruna, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25661-w · Cited by 83
Self-citationThe challenge of intratumour heterogeneity in precision medicine
Seoane, J., & Mattos‐Arruda, L. D. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12240 · Cited by 85
The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks
Vázquez-Arreguín, K., & Tantin, D. R. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.02.007 · Cited by 85
Hitti, E., Bakheet, T. M., Al‐Souhibani, N., Moghrabi, W. N., Al‐Yahya, S., Alghamdi, M. A., Al‐Saif, M., Shoukri, M. M., Lánczky, A., Grépin, R., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3110 · Cited by 83
Fusco, N., Geyer, F. C., Filippo, M. R. D., Martelotto, L. G., Ng, C. K. Y., Piscuoglio, S., Guerini‐Rocco, E., Schultheis, A. M., Fuhrmann, L., Wang, L., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.134 · Cited by 85
Self-citationChang, Y.-W., Tseng, C.-F., Wang, M.-Y., Chang, W.-C., Lee, C.-C., Chen, L.-T., Hung, M.-C., & Su, J.-L. (2016) · Oncogene · doi:10.1038/onc.2015.214 · Cited by 82
Targeted therapies for ER+/HER2- metastatic breast cancer
Yamamoto‐Ibusuki, M., Arnedos, M., & André, F. (2015) · BMC Medicine · doi:10.1186/s12916-015-0369-5 · Cited by 85
Lauriola, M., Enuka, Y., Zeisel, A., D’Uva, G., Roth, L. E., Sevilla-Sharon, M., Lindzen, M., Sharma, K., Nevo, N., Feldman, M. E., et al. (2014) · Nature Communications · doi:10.1038/ncomms6073 · Cited by 84
System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue Homeostasis
Pozniak, Y., Balint‐Lahat, N., Rudolph, J. D., Lindskog, C., Katzir, R., Avivi, C., Pontén, F., Ruppin, E., Barshack, I., & Geiger, T. (2016) · Cell Systems · doi:10.1016/j.cels.2016.02.001 · Cited by 83
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer
Álvarez‐Fernández, M., Sanz‐Flores, M., Sanz‐Castillo, B., Salazar‐Roa, M., Partida, D., Zapatero‐Solana, E., Ali, H. R., Manchado, E., Lowe, S. W., VanArsdale, T. L., et al. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0024-0 · Cited by 82
Self-citationMutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases
Schrijver, W. A. M. E., Selenica, P., Lee, J. Y., Ng, C. K. Y., Burke, K. A., Piscuoglio, S., Berman, S., Reis-Filho, J. S., Weigelt, B., van Diest, P. J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2310 · Cited by 82
Bayraktar, R., Ivan, C., Bayraktar, E., Kanlikilicer, P., Kabil, N. N., Kahraman, N., Mokhlis, H. A., Karakaş, D., Rodriguez‐Aguayo, C., Arslan, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1959 · Cited by 83
Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy
Khouzam, R. A., Venkatesh, G. H., Zaarour, R. F., Chamseddine, A. N., Francis, A., Buart, S., Terry, S., & Chouaïb, S. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.003 · Cited by 84
Takahashi, H., Asaoka, M., Yan, L., Rashid, O. M., Oshi, M., Ishikawa, T., Nagahashi, M., & Takabe, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-58995-4 · Cited by 84
Onkar, S., Cui, J., Zou, J., Cardello, C., Cillo, A. R., Uddin, M. R., Sagan, A., Joy, M., Osmanbeyoglu, H. U., Pogue–Geile, K. L., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00527-w · Cited by 82
Tanvir, R. B., Islam, M. M., Sobhan, M., Luo, D., & Mondal, A. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052788 · Cited by 82
Molecular characterisation of cell line models for triple-negative breast cancers
Grigoriadis, A. E., Mackay, A. G., Noel, E. E., Wu, P., Natrajan, R., Frankum, J. R., Reis-Filho, J. S., & Tutt, A. N. J. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-619 · Cited by 88
Magnani, L., Frigè, G., Gadaleta, R. M., Corleone, G., Fabris, S., Kempe, H., Verschure, P. J., Barozzi, I., Vircillo, V., Hong, S.-P., et al. (2017) · Nature Genetics · doi:10.1038/ng.3773 · Cited by 82
NOTCH3 expression is linked to breast cancer seeding and distant metastasis
Leontovich, A. A., Jalalirad, M., Salisbury, J. L., Mills, L., Haddox, C. L., Schroeder, M. A., Tuma, A. C. M., Guicciardi, M. E., Zammataro, L. A., Gambino, M. W., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1020-0 · Cited by 82
Integrative clustering methods of multi‐omics data for molecule‐based cancer classifications
Wang, D., & Gu, J. (2016) · Quantitative Biology · doi:10.1007/s40484-016-0063-4 · Cited by 81
Xu, L., Vacher, S., Boulai, A., Bernard, V., Baulande, S., Bohec, M., Bièche, I., Lerebours, F., & Callens, C. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1007-x · Cited by 81
MEST induces Twist-1-mediated EMT through STAT3 activation in breast cancers
Kim, M. S., Lee, H. S., Kim, Y. J., Lee, D. Y., Kang, S. G., & Jin, W. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0322-9 · Cited by 84
Malik, N., Yan, H., Moshkovich, N., Palangat, M., Yang, H. H., Sanchez, V. C., Cai, Z., Peat, T. J., Jiang, S., Liu, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10102-6 · Cited by 81
Xu, M., Li, Y., Li, W., Zhao, Q., Zhang, Q., Le, K., Huang, Z., & Yi, P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00064 · Cited by 81
Kumar, S., Nandi, A., Singh, S., Regulapati, R., Li, N., Tobias, J. W., Siebel, C. W., Blanco, M. A., Klein–Szanto, A. J., Lengner, C. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20664-5 · Cited by 81
Valdés‐Mora, F., Salomon, R., Gloss, B., Law, A. M. K., Venhuizen, J., Castillo, L. E., Murphy, K. J., Magenau, A., Papanicolaou, M., de la Fuente, L. R., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108945 · Cited by 82
Digital profiling of gene expression from histology images with linearized attention
Pizurica, M., Zheng, Y., Carrillo‐Pérez, F., Noor, H., Yao, W., Wohlfart, C., Vladimirova, A., Marchal, K., & Gevaert, O. (2024) · Nature Communications · doi:10.1038/s41467-024-54182-5 · Cited by 84
Breast tumor subgroups reveal diverse clinical prognostic power
Liu, Z., Zhang, X., & Zhang, S. (2014) · Scientific Reports · doi:10.1038/srep04002 · Cited by 81
Bai, F., Chan, H. L., Scott, A., Smith, M. D., Fan, C., Herschkowitz, J. I., Perou, C. M., Livingstone, A. S., Robbins, D. J., Capobianco, A. J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1119 · Cited by 84
Deep Survival: A Deep Cox Proportional Hazards Network.Preprint
Katzman, J., Shaham, U., Cloninger, A., Bates, J., Jiang, T., & Kluger, Y. (2016) · arXiv (Cornell University) · Cited by 81
Francesco, E. M. D., Sims, A. H., Maggiolini, M., Sotgia, F., Lisanti, M. P., & Clarke, R. B. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0923-5 · Cited by 80
Specific breast cancer prognosis‐subtype distinctions based on DNA methylation patterns
Zhang, S., Wang, Y., Gu, Y., Zhu, J., Ci, C., Guo, Z., Chen, C., Wei, Y., Lv, W., Liu, H., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12309 · Cited by 81
Casciano, J. C., Perry, C. E., Cohen-Nowak, A. J., Miller, K. D., Voorde, J. V., Zhang, Q., Chalmers, S., Sandison, M. E., Liu, Q., Hedley, A., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0711-3 · Cited by 80
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination
Chandler, B. C., Moubadder, L., Ritter, C. L., Liu, M., Cameron, M., Wilder-Romans, K., Zhang, A., Pesch, A. M., Michmerhuizen, A. R., Hirsh, N. H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130435 · Cited by 81
Jiang, L., Ren, L., Chen, H., Pan, J., Zhang, Z., Kuang, X., Chen, X., Bao, W., Lin, C., Zhou, Z., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02753-x · Cited by 80
TGFBI modulates tumour hypoxia and promotes breast cancer metastasis
Fico, F., & Santamaria‐Martínez, A. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12828 · Cited by 80
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Li, Z., McGinn, O., Wu, Y. F., Bahreini, A., Priedigkeit, N., Ding, K., Onkar, S., Lampenfeld, C., Sartorius, C. A., Miller, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29498-9 · Cited by 81
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
Cao, S., Wang, J. R., Ji, S., Peng, Y., Dai, Y., Guo, S., Montierth, M. D., Shen, J. P., Zhao, X. H., Chen, J., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01342-x · Cited by 81
Androgen receptor function and targeted therapeutics across breast cancer subtypes
Kolyvas, E. A., Caldas, C., Kelly, K., & Ahmad, S. S. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01574-4 · Cited by 80
Self-citationPKA signaling drives mammary tumorigenesis through Src
Beristain, A. G., Molyneux, S. D., Joshi, P. A., Pomroy, N. C., Grappa, M. A. D., Chang, M. C., Kirschner, L. S., Privé, G. G., Pujana, M. Á., & Khokha, R. (2014) · Oncogene · doi:10.1038/onc.2014.41 · Cited by 80
ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR
Thomas, C. G., Rajapaksa, G. K., Nikolos, F., Hao, R., Katchy, A., McCollum, C. W., Bondesson, M., Quinlan, P., Thompson, A. M., Krishnamurthy, S., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3358 · Cited by 80
A pathway-based data integration framework for prediction of disease progression
Seoane, J. A., Day, I. N. M., Gaunt, T. R., & Campbell, C. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt610 · Cited by 80
Glubb, D. M., Maranian, M. J., Michailidou, K., Pooley, K. A., Meyer, K. B., Kar, S., Carlebur, S., O’Reilly, M., Betts, J. A., Hillman, K. M., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.11.009 · Cited by 81
Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival
Fink, S. P., Myeroff, L. L., Kariv, R., Platzer, P., Xin, B., Mikkola, D. L., Lawrence, E., Morris, N. J., Nosrati, A., Willson, J. K. V., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5921 · Cited by 80
Vural, S., Wang, X., & Guda, C. (2016) · BMC Systems Biology · doi:10.1186/s12918-016-0306-z · Cited by 80
Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge
Goffin, V. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.009 · Cited by 82
A review on radiomics and the future of theranostics for patient selection in precision medicine
Keek, S. A., Leijenaar, R. T. H., Jochems, A., & Woodruff, H. C. (2018) · British Journal of Radiology · doi:10.1259/bjr.20170926 · Cited by 80
A microRNA Signature Associated with Early Recurrence in Breast Cancer
Pérez-Rivas, L. G., Jerez, J. M., Carmona, R., de Luque, V., Vicioso, L., Claros, M. G., Viguera, E., Pajares, B., Sánchez, A., Ribelles, N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091884 · Cited by 67
Tanioka, M., Fan, C., Parker, J. S., Hoadley, K. A., Hu, Z., Yan, L., Hyslop, T., Pitcher, B. N., Soloway, M. G., Spears, P. A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3431 · Cited by 79
Metzger, O., Stover, D. G., Asad, S., Ansell, P. J., Watson, M. A., Loibl, S., Geyer, C. E., Bae, J., Collier, K. A., Cherian, M. A., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.7310 · Cited by 79
Ji, P., Gong, Y., Jin, M., Wu, H., Guo, L., Pei, Y., Chai, W.-J., Jiang, Y., Liu, Y., Ma, X.-Y., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl8247 · Cited by 79
Omics-Based Investigations of Breast Cancer
Neagu, A.-N., Whitham, D., Bruno, P. S., Morrissiey, H., Darie, C. A., & Darie, C. C. (2023) · Molecules · doi:10.3390/molecules28124768 · Cited by 81
MicroRNAs and Triple Negative Breast Cancer
D’Ippolito, E., & Iorio, M. V. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122202 · Cited by 83
Albarakati, N., Abdel-Fatah, T. M. A., Doherty, R. E., Russell, R., Agarwal, D., Moseley, P. M., Perry, C., Arora, A., Alsubhi, N. H., Seedhouse, C., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.08.001 · Cited by 79
Self-citationDetection of cancer before distant metastasis
Coumans, F. A. W., Siesling, S., & Terstappen, L. W. M. M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-283 · Cited by 79
Soncini, D., Caffa, I., Zoppoli, G. M., Cea, M., Cagnetta, A., Passalacqua, M., Mastracci, L., Boero, S., Montecucco, F., Sociali, G., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594721 · Cited by 79
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells
Barutcu, A. R., Hong, D., Lajoie, B. R., McCord, R. P., van Wijnen, A. J., Lian, J. B., Stein, J. L., Dekker, J., Imbalzano, A. N., & Stein, G. S. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.08.003 · Cited by 80
Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
Liu, J. C., Granieri, L., Shrestha, M., Wang, D., Vorobieva, I., Rubie, E. A., Jones, R. A., Ju, Y., Pellecchia, G., Jiang, Z., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.039 · Cited by 80
Breast cancer intratumour heterogeneity: current status and clinical implications
Joseph, C., Papadaki, A., Althobiti, M. M., Alsaleem, M. A., Aleskandarany, M. A., & Rakha, E. A. (2018) · Histopathology · doi:10.1111/his.13642 · Cited by 79
The Omics of Triple-Negative Breast Cancers
Xu, H., Eirew, P. D., Mullaly, S. C., & Aparicio, S. A. J. R. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.207167 · Cited by 80
Self-citationCampbell, T. M., Castro, M. A. A., de Oliveira, K. G., Ponder, B. A. J., & Meyer, K. B. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1153 · Cited by 78
Emerging roles of long non-coding RNAs in breast cancer biology and management
Amelio, I., Bernassola, F., & Candi, E. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.019 · Cited by 78
Lotfinejad, P., Kazemi, T., Safaei, S., Amini, M. A., Asl, E. R., Baghbani, E., Shotorbani, S. S., Jadidi‐Niaragh, F., Derakhshani, A., Shadbad, M. A., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111436 · Cited by 81
Dynamic roles of inflammasomes in inflammatory tumor microenvironment
Jang, J., Kim, D., & Surh, Y. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00154-7 · Cited by 79
Silveira, A. B., Bidard, F., Tanguy, M., Girard, E., Trédan, O., Dubot, C., Jacot, W., Gonçalvès, A., Debled, M., Lévy, C., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00319-4 · Cited by 78
Age-associated differences in the cancer molecular landscape
Chatsirisupachai, K., Lagger, C., & de Magalhães, J. P. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.06.007 · Cited by 83
CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope
Karn, V., Sandhya, S., Hsu, W., Parashar, D., Singh, H. N., Jha, N. K., Gupta, S. K., Dubey, N. K., & Kumar, S. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02654-3 · Cited by 85
Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer
Wiecek, A. J., Cutty, S. J., Kornai, D., Parreno-Centeno, M., Gourmet, L. E., Tagliazucchi, G. M., Jacobson, D. H., Zhang, P., Xiong, L., Bond, G. L., et al. (2023) · Genome biology · doi:10.1186/s13059-023-02963-4 · Cited by 83
Lee, C. Y. C., Kennedy, B. C., Richoz, N., Dean, I., Tuong, Z. K., Gaspal, F., Li, Z., Willis, C., Hasegawa, T., Whiteside, S. K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44787-1 · Cited by 82
Chan, H. J., Li, H., Liu, Z., Yuan, Y., Mortimer, J. E., & Chen, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4441 · Cited by 78
Self-citationPP2A: The Wolf in Sheep’s Clothing?
Bailey‐Whyte, M., & Kiely, P. (2015) · Cancers · doi:10.3390/cancers7020648 · Cited by 82
Stein, R. C., Dunn, J., Bartlett, J. M. S., Campbell, A. F., Marshall, A., Hall, P. S., Rooshenas, L., Morgan, A. A., Poole, C. J., Pinder, S. E., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20100 · Cited by 82
Self-citationTumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
Goetz, M. P., Kalari, K. R., Suman, V. J., Moyer, A. M., Yu, J., Visscher, D. W., Dockter, T., Vedell, P. T., Sinnwell, J. P., Tang, X., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw306 · Cited by 78
Avanzato, D., Pupo, E., Ducano, N., Isella, C., Bertalot, G., Luise, C., Pece, S., Bruna, A., Rueda, O. M., Caldas, C., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3018 · Cited by 82
Self-citationNetanely, D., Avraham, A., Ben‐Baruch, A., Evron, E., & Ron Shamir, A. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0724-2 · Cited by 77
Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers
Aiderus, A., Black, M. A., & Dunbier, A. K. (2018) · BMC Cancer · doi:10.1186/s12885-018-4626-9 · Cited by 80
Jin, Y., Zhang, Y., Li, B., Zhang, J., Dong, Z., Hu, X., & Wan, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.269 · Cited by 77
Zhou, S., Huang, Y., Liu, H., Zhou, X., Yuan, M., Hou, F., Wang, L., & Jiang, W. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.018 · Cited by 78
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
Lee, J. V., Housley, F., Yau, C. S. F., Nakagawa, R. M., Winkler, J., Anttila, J. M., Munne, P., Savelius, M., Houlahan, K. E., de Mark, D. V., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31238-y · Cited by 81
Self-citationMoanna: Multi-Omics Autoencoder-Based Neural Network Algorithm for Predicting Breast Cancer Subtypes
Lupat, R., Perera, R. D., Loi, S., & Li, J. (2023) · IEEE Access · doi:10.1109/access.2023.3240515 · Cited by 77
Corda, G., Sala, G., Lattanzio, R., Iezzi, M., Sallese, M., Fragassi, G., Lamolinara, A., Mirza, H., Barcaroli, D., Ermler, S., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4841 · Cited by 82
Metadata
- Authors
- METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., Yuan, Y., Gräf, S., Ha, G., Haffari, G., Bashashati, A., Russell, R., McKinney, S., Langerød, A., Green, A., Provenzano, E., Wishart, G., Pinder, S., Watson, P., Markowetz, F., Murphy, L., Ellis, I., Purushotham, A., Børresen-Dale, A.-L., Brenton, J. D., Tavaré, S., Caldas, C., & Aparicio, S.
- Affiliations
- University of Cambridge (GB)
- University of British Columbia (CA)
- Oslo University Hospital (NO)
- University of Nottingham (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- King's College London (GB)
- University of Southern California (US)
- Corresponding author
- Caldas, Carlos
- Aparicio, Samuel
- ORCID
- Curtis, Christina
- Shah, Sohrab P.
- Chin, Suet-Feung
- Turashvili, Gulisa
- Rueda, Oscar M.
- Dunning, Mark J.
- Speed, Doug
- Lynch, Andy G.
- Samarajiwa, Shamith
- Yuan, Yinyin
- Gräf, Stefan
- Ha, Gavin
- Haffari, Gholamreza
- Bashashati, Ali
- Green, Andrew
- Provenzano, Elena
- Wishart, Gordon
- Pinder, Sarah
- Watson, Peter
- Markowetz, Florian
- Murphy, Leigh
- Ellis, Ian
- Purushotham, Arnie
- Brenton, James D.
- Tavaré, Simon
- Caldas, Carlos
- Aparicio, Samuel
- Venue
- Nature
- Published
- 2012-04-18
- Volume
- 486
- Issue
- 7403
- Pages
- 346-352
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3440846
- OpenAlex
- W2005895632
- Cited by
- 6,097
- References
- 32
- Citations by year
- 2026: 341 · 2025: 411 · 2024: 458 · 2023: 497 · 2022: 496 · 2021: 615 · 2020: 533 · 2019: 449 · 2018: 426 · 2017: 361 · 2016: 373 · 2015: 378 · 2014: 339 · 2013: 291 · 2012: 119
- FWCI
- 119.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- University of Southern California
- Michael Smith Health Research BC
- Cancer Research UK (A7199, 15601, 19556)
- National Institute for Health and Care Research (ACF-2012-14-006, NF-SI-0611-10154)
- University of Cambridge
- King's College London
- National Institutes of Health
- BC Cancer Agency
- NIHR Cambridge Biomedical Research Centre
- National Human Genome Research Institute (P50-HG02790, P50HG002790)
- Division of Mathematical Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- breast cancer, copy number alterations, somatic copy number alterations, gene expression, single nucleotide polymorphisms, PPP2R2A, MTAP, MAP2K4, estrogen receptor-positive breast cancer, adaptive immune response, basal-like breast cancer, chromosome 5 deletion, molecular stratification, prognosis
- MeSH terms
- Breast Neoplasms, Female, Humans, Prognosis, Genome, Human, Gene Expression Regulation, Neoplastic, Treatment Outcome, Polymorphism, Single Nucleotide, Gene Expression Profiling, Genomics, MAP Kinase Kinase 4, Genes, Neoplasm, Kaplan-Meier Estimate, Gene Regulatory Networks, Protein Phosphatase 2, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
